Concepedia

Ping Xiang

PX

17

Publications

1.5K

Citations

14

H-Index

2008

Active since

Affiliations

Huadong Hospital(Current)

Eli Lilly (United States)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Fudan University

Ping Xiang is an author at Huadong Hospital specializing in medicine, health sciences, and physiology.

ORCID

Top concepts

Publications per year

2008–2023

17

Publications

17

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · 2020 · 173 citations · Full text

Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model

Ping Xiang, Hai Yan Deng, Karen Li et al. · Cancer Chemotherapy and Pharmacology · 2008 · 56 citations

, , +11

Glucocorticoids decrease body weight and food intake and inhibit appetite regulatory peptide expression in the hypothalamus of rats

Xiaoyan Liu, Shi JianHua, Wen-Hua Du et al. · Experimental and Therapeutic Medicine · 2011 · 52 citations · Full text

, , +18

Rows per page

1–5 of 17